Patents Assigned to Illumenex Corporation
  • Patent number: 6263236
    Abstract: Non-occluding catheters and methods for delivering energy to a vessel wall without occluding blood flow through the vessel wall are disclosed. In particular, the invention uses an energy distributor connected to an expansion mechanism and a waveguide. The expansion mechanism causes the distributor to come into close proximity with a target region in the vessel wall, while maintaining at least one fluid passageway for blood flow throughout the instrument.
    Type: Grant
    Filed: November 29, 1999
    Date of Patent: July 17, 2001
    Assignee: Illumenex Corporation
    Inventors: Michael Kasinkas, Robert Ziebol
  • Patent number: 6200307
    Abstract: A method for treating in-stent restenosis using radiation having a wavelength sufficient to kill or promote cellular death (e.g., through programmed cell death), or otherwise remove smooth muscle cells which have proliferated, or which might otherwise proliferate, in the proximity of (i.e., within, around or adjacent to) a stent within a body lumen, causing (or potentially causing) at least partial blockage of the lumen. The treatment method includes irradiating smooth muscle cells in the region of the stenosis with non-ablative, cytotoxic radiation, such as UV radiation. A cytotoxic, photoactivatable chromophore may also be delivered to the treatment site prior to irradiation. The method can be used prophylactically or to treat in-stent restenosis after blockage has occurred without further damage to surrounding tissue.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: March 13, 2001
    Assignee: Illumenex Corporation
    Inventors: Michael Kasinkas, Robert A. Van Tassel
  • Patent number: 5964751
    Abstract: A light delivery system for use in irradiating vascular tissue includes a balloon catheter with a working lumen for receiving an optical fiber therein and an inflation/flushing lumen adapted to receive a liquid at a proximal end and leading to a space defined within the balloon member attached to a distal end of the catheter. The balloon member has a pattern of holes or pores in the wall thereof through which the saline may flow when the balloon is inflated, causing any blood or other absorbing substances that may interfere with good radiant energy transmission to be flushed away from the treatment site.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: October 12, 1999
    Assignee: Illumenex Corporation
    Inventors: Curtis A. Amplatz, Mark A. Rydell, Robert J. Ziebol, Christopher H. Porter, Michael Kasinkas
  • Patent number: 5833682
    Abstract: A light delivery system for use in irradiating vascular tissue includes a balloon catheter with a working lumen for receiving an optical fiber therein and an inflation/flushing lumen adapted to receive a liquid at a proximal end and leading to a space defined within the balloon member attached to a distal end of the catheter. The balloon member has a pattern of holes or pores in the wall thereof through which the saline may flow when the balloon is inflated, causing any blood or other absorbing substances that may interfere with good radiant energy transmission to be flushed away from the treatment site.
    Type: Grant
    Filed: August 26, 1996
    Date of Patent: November 10, 1998
    Assignee: Illumenex Corporation
    Inventors: Curtis A. Amplatz, Mark A. Rydell, Robert J. Ziebol, Christopher H. Porter, Michael Kasinkas
  • Patent number: 5776174
    Abstract: Ultraviolet radiation can be used to treat vascular diseases. In particular, for unstable lesions where angioplasty may not be warranted, cytotoxic, nonablative ultraviolet radiation, preferably at a wavelength in the range of about 240 to about 280 nanometers, can be used to disable the intima and reduce spasms associated with partially occluded blood vessels.
    Type: Grant
    Filed: January 30, 1995
    Date of Patent: July 7, 1998
    Assignee: Illumenex Corporation
    Inventor: Robert A. Van Tassel